Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

6301 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
79-11        Takecab Takeda Pharmaceutical Company Limited (武田薬品工業株式会社) Original drug not imported to China Approved in Japan The 79th Batch of Reference Listed Drugs
79-12        Takecab Takeda Pharmaceutical Company Limited (武田薬品工業株式会社) Original drug not imported to China Approved in Japan The 79th Batch of Reference Listed Drugs
79-13        FANAPT Vanda Pharmaceuticals Inc. Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-14        FANAPT Vanda Pharmaceuticals Inc Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-15        FANAPT Vanda Pharmaceuticals Inc Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-16        FANAPT Vanda Pharmaceuticals Inc Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-17        FANAPT Vanda Pharmaceuticals Inc Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-18        FANAPT Vanda Pharmaceuticals Inc Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-19        FANAPT Vanda Pharmaceuticals Inc Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs
79-20        IXEMPRA KIT R-Pharm US LLC Original drug not imported to China US Orange Book The 79th Batch of Reference Listed Drugs